Adult-onset autoimmune diabetes in Europe is prevalent with a broad clinical phenotype: Action LADA 7. - Wikidata - awgldk - TriplyDB

Adult-onset autoimmune diabetes in Europe is prevalent with a broad clinical phenotype: Action LADA 7.

Adult-onset autoimmune diabetes in Europe is prevalent with a broad clinical phenotype: Action LADA 7.

http://www.wikidata.org/entity/Q30538087

about

Treatment intensification in patients with inadequate glycemic control on basal insulin: rationale and clinical evidence for the use of short-acting and other glucagon-like peptide-1 receptor agonists Type 1 diabetes through the life span: a position statement of the American Diabetes Association Epidemiology of Fractures in Diabetes.Distinct clinical and laboratory characteristics of latent autoimmune diabetes in adults in relation to type 1 and type 2 diabetes mellitus.Relative contribution of type 1 and type 2 diabetes loci to the genetic etiology of adult-onset, non-insulin-requiring autoimmune diabetes Increased seroreactivity to proinsulin and homologous mycobacterial peptides in latent autoimmune diabetes in adults.Approach to the patient with atypical diabetes.Challenges in diagnosis and management of diabetes in the young.Early prediction of autoimmune (type 1) diabetes.Comprehensive biomarker testing of glycemia, insulin resistance, and beta cell function has greater sensitivity to detect diabetes risk than fasting glucose and HbA1c and is associated with improved glycemic control in clinical practice Islet autoimmunity identifies a unique pattern of impaired pancreatic beta-cell function, markedly reduced pancreatic beta cell mass and insulin resistance in clinically diagnosed type 2 diabetes Alcohol and the risk for latent autoimmune diabetes in adults: results based on Swedish ESTRID study Fatty fish consumption and risk of latent autoimmune diabetes in adults.Personalizing guidelines for diabetes management: twilight or dawn of the expert?Personalized medicine: risk prediction, targeted therapies and mobile health technology.Diabetic ketoacidosis as first presentation of latent autoimmune diabetes in adult Latent Autoimmune Diabetes in Adults in the United Arab Emirates: Clinical Features and Factors Related to Insulin-Requirement Glutamic acid decarboxylase autoantibodies are dominant but insufficient to identify most Chinese with adult-onset non-insulin requiring autoimmune diabetes: LADA China study 5.Mortality in adult-onset autoimmune diabetes is associated with poor glycemic control: results from the HUNT Study Relationship between autoantibodies combination, metabolic syndrome components and diabetic complications in autoimmune diabetes in adults.Latent autoimmune diabetes of the adult: current knowledge and uncertainty The emerging global epidemic of type 1 diabetes.Diabetes at the crossroads: relevance of disease classification to pathophysiology and treatment.Preclinical carotid atherosclerosis in patients with latent autoimmune diabetes in adults (LADA), type 2 diabetes and classical type 1 diabetes.Rationale and protocol for the After Diabetes Diagnosis REsearch Support System (ADDRESS): an incident and high risk type 1 diabetes UK cohort study.Clinical heterogeneity of type 1 diabetes (T1D) found in Asia.Incidence of type 1 diabetes in age groups above 15 years: facts, hypothesis and prospects for future epidemiologic research.Should There be Concern About Autoimmune Diabetes in Adults? Current Evidence and Controversies.Latent autoimmune diabetes in adults (LADA) in Asian and European populations.Clustering of immunological, metabolic and genetic features in latent autoimmune diabetes in adults: evidence from principal component analysis.Saxagliptin improves glycaemic control and C-peptide secretion in latent autoimmune diabetes in adults (LADA).Autoimmune diabetes in adults and risk of myocardial infarction: the HUNT study in Norway.Low birthweight is associated with an increased risk of LADA and type 2 diabetes: results from a Swedish case-control study.The heterogeneity of islet autoantibodies and the progression of islet failure in type 1 diabetic patients.Glutamic acid decarboxylase and islet antigen 2 antibody profiles in people with adult-onset diabetes mellitus: a comparison between mixed ethnic populations in Singapore and Germany.High Prevalence of Autoimmune Diabetes and Poor Glycaemic Control among Adults in Madagascar: A Brief Report from a Humanitarian Health Campaign in Ambanja.Recognizing and Appropriately Treating Latent Autoimmune Diabetes in Adults.Small Fiber Neuropathy in Patients With Latent Autoimmune Diabetes in Adults.Latent autoimmune diabetes in adults presenting as diabetes "recurrence" after bariatric surgery: a case report.Late-onset type 1 diabetes in Pāsifika migrants living in Auckland.

P2860

Q28077026-832D6189-0DC0-488E-A6C8-5C524F617C82 Q28242092-8C32806E-B8F7-4DF0-B279-FBA7F3D3FA0F Q30248863-69A90ADF-814D-4BFC-8DE0-C321D9B2ED46 Q33358948-1E9EDFC3-A20F-47DF-BDA7-D5B619CAF1B8 Q33601181-409B6C0B-4887-412B-AFD7-767FE1AC220B Q33637536-4B90C0CE-B721-4865-AFE7-63F7DB9E17B7 Q33728464-17297191-B72A-4A3B-80BF-5846CD490267 Q33801559-FCC58CCD-A37C-41FB-A6ED-69B4B964FCC6 Q33854613-DB01D80C-F1D3-445E-8A5C-EF42D8431E3E Q34062993-EC00BFF3-E652-4A13-BAD9-EC62D39F84ED Q34194600-0930F08C-731A-4781-8BD7-62068C600097 Q34310431-8BF75DDB-4FCD-4A0C-A899-487827D65F0B Q34439877-7F2139F4-B223-4668-B650-89622A1F79A2 Q34810165-2C95946E-86F8-4EF2-983F-3346683EA406 Q35104761-52FEBCD2-37BD-4EBC-8284-E1D1462AE0EF Q35193550-7DC40A0E-509E-404F-A619-4A73B9CA5DE0 Q35740110-A0B88916-8B86-4371-AACD-DE0846E525FE Q36234353-533CA312-407E-471B-95D6-04F3C4AB8499 Q37331257-FB1C59E6-CEE5-4EAC-A093-18AC5714D83D Q38223492-323D0EC5-D6F9-4260-A83A-E7D7582379BD Q38324198-E1484314-B5D2-4958-961D-F42400CB6206 Q38424292-CABAA920-DF70-4A35-ADB1-8D6128B7CBAF Q38615808-857F9C78-08D6-4918-A02E-891830FA91FE Q38657107-839DBEC5-B4A2-43EE-80AF-F97865BFCE89 Q38657961-10997920-E79E-401D-A1A0-FD204F52F25D Q38679002-A246918E-BD02-4E97-A0AE-012B6F4F036F Q38703570-77303799-577C-4842-89DE-94C019138262 Q38908327-5010F396-1F35-4845-920F-612A490EE708 Q39136099-12B35A85-95F4-4C92-944C-DA42C32C23A9 Q40268701-D799CC5C-4E73-4F11-8893-081D0754E391 Q40524112-3551C0F1-39BE-4AE3-99AF-9754C85B0DE4 Q40533741-02AB3C46-C7DF-4321-9008-2E8C86D0DCDC Q40699284-A6B8898B-1EFA-4777-877C-F78DFA381BE5 Q40735953-A156C6C0-7C9C-436F-B370-643FCFFE726A Q41551735-EA62FEF9-053A-4A3D-88FF-B1FCB8AAE58E Q41987413-794E9A18-D3AC-43EB-8CBD-3D8AE12416B4 Q42748372-A078FC0F-7265-4629-91CA-E0CF802A25F9 Q42769096-5D0B836A-6A7A-428C-950D-D49B8CBE36CF Q43087653-30C359EE-4554-4DEB-9237-DE61E17E1B12 Q44595464-3078EE77-83C2-4A0E-B6C9-0C105344F706

P2860

Adult-onset autoimmune diabetes in Europe is prevalent with a broad clinical phenotype: Action LADA 7.

http://www.wikidata.org/entity/Q30538087

description

2012 nî lūn-bûn

@nan

2012 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած

@hyw

2012 թվականի դեկտեմբերին հրատարակված գիտական հոդված

@hy

2012年の論文

@ja

2012年論文

@yue

2012年論文

@zh-hant

2012年論文

@zh-hk

2012年論文

@zh-mo

2012年論文

@zh-tw

2012年论文

@wuu

name

Adult-onset autoimmune diabete ...... ical phenotype: Action LADA 7.

@ast

Adult-onset autoimmune diabete ...... ical phenotype: Action LADA 7.

@en

type

label

Adult-onset autoimmune diabete ...... ical phenotype: Action LADA 7.

@ast

Adult-onset autoimmune diabete ...... ical phenotype: Action LADA 7.

@en

prefLabel

Adult-onset autoimmune diabete ...... ical phenotype: Action LADA 7.

@ast

Adult-onset autoimmune diabete ...... ical phenotype: Action LADA 7.

@en

P1433

Q30538087-92C41D17-BD88-4D33-BD1B-2F7E43299DA8

P1476

Q30538087-99E26473-5394-4F3B-B117-F140C24B1207

P2093

Q30538087-11B77CB0-54E2-486C-B43F-DDE5AC916AA6

Q30538087-28AE2371-F456-47AD-B7F6-AEF87AE924A3

Q30538087-2FE1A76D-D991-4721-9812-47FF20D3C0C7

Q30538087-5A19AE9B-EDDA-4356-873F-A4D702922BBB

Q30538087-7A38337D-C329-4B7A-BF78-74CD5767102F

Q30538087-8514E561-1819-4ABD-A16E-468874C4C938

Q30538087-89A230C5-312B-400C-99D9-D9236CC3A6D2

Q30538087-8A5E8C19-F55B-4083-BB9E-070A9BE79F7B

Q30538087-93D1AC10-3FA2-4D21-B04A-2BDB60619D25

Q30538087-98AA7393-5896-44BB-BB03-AFA3119EF171

P2860

Q30538087-1C2FC3DF-4389-45E1-B045-3C46A08CD11A

Q30538087-3E6FD323-4044-41FF-896D-5A8EC8C12530

Q30538087-5D2CDC57-2AE3-4F4B-B637-F61A295EDF7B

Q30538087-68BA8767-4256-4721-8C42-32AC964EEB3F

Q30538087-757A2553-761A-4606-BAD8-6A5FEB334D4C

Q30538087-82205C8A-F6D5-4CB5-B320-DC6B5BF489B4

Q30538087-826863F7-287D-4E6E-9785-B7C0C73B228F

Q30538087-92D4393E-7CD9-45CC-BE15-EE1293844A33

Q30538087-9E59CCEF-F662-40F0-AC21-386DE1FDA9C9

Q30538087-A747EC15-CF59-4199-905D-67993926333F

P304

Q30538087-47244A4F-9535-473C-9D57-C1FA90DDCBA6

P31

Q30538087-401EF272-040B-49BD-81EF-B3242B1CD5E5

P356

Q30538087-E0300E13-B138-48E6-B20B-BC6698A42158

P407

Q30538087-DB94BDE7-5A5D-46BE-BAF7-817D0FDCDEDC

P433

Q30538087-1C5FBAFE-4282-43C0-93D3-8111D0AC2C65

P478

Q30538087-71ED445A-1DD1-45B4-BB16-F3DC2CD9C51E

P50

Q30538087-1BC0774D-3AE6-40C8-B66C-E85B4104C886

Q30538087-40DB91B4-ADD6-4011-8920-071D4E5FC618

Q30538087-44E526CD-1F86-47EB-BD85-82C4860C673E

Q30538087-737AB499-EA61-4297-8CF7-CAF3ADB94160

Q30538087-CC18DAFD-EF39-4492-9716-8AB866DB6C6B

Q30538087-DBBA6C00-FD1E-439D-A030-8E94B7528121

P577

Q30538087-1D99F4DB-CB23-48AE-BC68-51E9A7FF62A0

P5875

Q30538087-460FC333-BB6E-4066-80B9-E268589BBB1D

P698

Q30538087-1FC3B906-A1FD-4460-B300-CD847C827C9E

P932

Q30538087-C20F7F75-1101-4B06-86A2-25B3DEC086E3

P356

P1433

P1476

Adult-onset autoimmune diabete ...... ical phenotype: Action LADA 7.

@en

P2093

Action LADA consortium

http://www.w3.org/2001/XMLSchema#string

Alberto De Leiva

http://www.w3.org/2001/XMLSchema#string

Charles Thivolet

http://www.w3.org/2001/XMLSchema#string

Cinzia Sarti

http://www.w3.org/2001/XMLSchema#string

David Hadden

http://www.w3.org/2001/XMLSchema#string

Guntram Schernthaner

http://www.w3.org/2001/XMLSchema#string

Henning Beck-Neilsen

http://www.w3.org/2001/XMLSchema#string

Hubert Kolb

http://www.w3.org/2001/XMLSchema#string

Huriya Beyan

http://www.w3.org/2001/XMLSchema#string

Mohammed I Hawa

http://www.w3.org/2001/XMLSchema#string

P2860

The cation efflux transporter ZnT8 (Slc30A8) is a major autoantigen in human type 1 diabetes

Genetics, pathogenesis and clinical interventions in type 1 diabetes

Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus

Diabetes and gender.

Latent autoimmune diabetes in adults (LADA) should be less latent.

Is latent autoimmune diabetes in adults distinct from type 1 diabetes or just type 1 diabetes at an older age?

Clinical review: Type 1 diabetes and latent autoimmune diabetes in adults: one end of the rainbow.

Metabolic syndrome and autoimmune diabetes: action LADA 3.

Diabetes classification: grey zones, sound and smoke: Action LADA 1.

Similar genetic features and different islet cell autoantibody pattern of latent autoimmune diabetes in adults (LADA) compared with adult-onset type 1 diabetes with rapid progression.

P304

908-913

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.2337/DC12-0931

http://www.w3.org/2001/XMLSchema#string

P407

P433

4

http://www.w3.org/2001/XMLSchema#string

P478

36

http://www.w3.org/2001/XMLSchema#string

P50

Jaakko Tuomilehto

Raffaella Buzzetti

Knud Yderstraede

P577

2012-12-17T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

233941854

http://www.w3.org/2001/XMLSchema#string

P698

23248199

http://www.w3.org/2001/XMLSchema#string

P932

3609504

http://www.w3.org/2001/XMLSchema#string